Serum β-HCG Level is a Prognostic Factor in Patients Receiving Second-line Chemotherapy for Transitional Cell Carcinoma of the Urothelial Tract (TCCUT)

Clinical Oncology(2014)

引用 0|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要